RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 45 filers reported holding RAIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $78,551 | -48.5% | 91,148 | -28.2% | 0.00% | – |
Q2 2023 | $152,392 | -36.8% | 126,993 | +360.3% | 0.00% | – |
Q1 2023 | $241,154 | +105.1% | 27,592 | +87.8% | 0.00% | – |
Q4 2022 | $117,568 | +80.9% | 14,696 | +10.4% | 0.00% | – |
Q3 2022 | $65,000 | -18.8% | 13,315 | -8.4% | 0.00% | – |
Q2 2022 | $80,000 | -87.1% | 14,530 | -88.1% | 0.00% | – |
Q1 2022 | $618,000 | -33.5% | 121,824 | +69.0% | 0.00% | – |
Q4 2021 | $929,000 | -10.9% | 72,097 | +3.4% | 0.00% | – |
Q3 2021 | $1,043,000 | -12.0% | 69,693 | -8.6% | 0.00% | – |
Q2 2021 | $1,185,000 | – | 76,272 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,560,652 | $7,616,000 | 1.78% |
Cormorant Asset Management, LP | 2,326,660 | $11,354,000 | 0.79% |
BVF INC/IL | 3,526,729 | $17,210,000 | 0.71% |
Perceptive Advisors | 2,483,619 | $12,120,000 | 0.35% |
Boxer Capital, LLC | 1,175,000 | $5,734,000 | 0.32% |
UBS OCONNOR LLC | 326,451 | $1,593,000,000 | 0.03% |
Ergoteles LLC | 65,096 | $318,000 | 0.01% |
Lumina Fund Management LLC | 6,000 | $29,000 | 0.01% |
Laurion Capital Management LP | 313,200 | $1,528,000 | 0.01% |
Woodline Partners LP | 119,700 | $584,000 | 0.01% |